Ventrocare Pharmaceuticals Private Limited

Ventrocare Pharmaceuticals Private Limited - chemicals in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24230TG2016PTC112512 Incorporated 19 October 2016 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company chemicals
Revenue · FY 2020
₹8.02 Lakh
▼ 78% YoY
Net loss · FY 2020
₹5.71 Lakh
Net margin -71.2%
EBITDA · FY 2020
-₹5.62 Lakh
EBITDA margin -70.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
4
As per MCA filings
GST registrations
1
None active

About Ventrocare Pharmaceuticals Private Limited

Data last updated:

Ventrocare Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 October 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2016PTC112512. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jagadeeswar Reddy Chowdavaram and Vamsi Bhargavi Ponnapureddy.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 3 – 3 – 81/1 Baghameeri Near Hanuman Temple Kukatpally, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2020, the company reported a revenue of ₹8.02 Lakh, a decline of 78% compared to the previous year. For the same year it recorded a net loss of ₹5.71 Lakh (net margin -71.2%) and EBITDA of -₹5.62 Lakh (EBITDA margin -70.1%).

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230TG2016PTC112512
Registration Number 112512
Incorporation Date 19 October 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Ventrocare Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    3 – 3 – 81/1 Baghameeri Near Hanuman Temple Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Chemicals, Manufacturing, Other Chemical Product

To see the full contact details of Ventrocare Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Ventrocare Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Ventrocare Pharmaceuticals Private Limited

FY 2023 filings available

Ventrocare Pharmaceuticals Private Limited reported revenue of ₹8.02 Lakh (down 78% YoY) for FY 2020.

Revenue · FY 2020
₹8.02 Lakh ▼ 78%
Net loss · FY 2020
₹5.71 Lakh margin -71.2%
EBITDA · FY 2020
-₹5.62 Lakh margin -70.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 78%

Revenue fell 78% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations₹8.02 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.62 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.71 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin-70.1%
Net Profit Margin-71.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ventrocare Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ventrocare Pharmaceuticals Private Limited

Ventrocare Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jagadeeswar Reddy ChowdavaramDirector19 Oct 201610 Years 0 MonthsCurrent
Vamsi Bhargavi PonnapureddyDirector19 Oct 201610 Years 0 MonthsCurrent
Latha Kiran ChowdavaramDirector16 Apr 20188 Years 6 MonthsCurrent
Venkat Subba Reddy ChoudavaramDirector19 Oct 201610 Years 0 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ventrocare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ventrocare Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Ventrocare Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ventrocare Pharmaceuticals Private Limited has 5 board changes on record since 2016: 4 appointments and 1 cessation. The latest: Rakshitha Pathuri ceased to be Director on 20 Aug 2018.

AGM
Ventrocare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Ventrocare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Ceased
Rakshitha Pathuri ceased to be Director.
Appointed
Latha Kiran Chowdavaram was appointed as Director.
Appointed
Jagadeeswar Reddy Chowdavaram was appointed as Director.
Appointed
Vamsi Bhargavi Ponnapureddy was appointed as Director.
Appointed
Venkat Subba Reddy Choudavaram was appointed as Director.
Incorporation
19 Oct 2016
Ventrocare Pharmaceuticals Private Limited was registered on 19 Oct 2016 with Roc Hyderabad & aged 10 years 27 days as per MCA records.

Frequently asked questions

Ventrocare Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 October 2016 (10+ years old) and is registered under CIN U24230TG2016PTC112512.

Ventrocare Pharmaceuticals has 4 current directors:

The latest financial statements of Ventrocare Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2017 are in the company report.

No. Ventrocare Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Ventrocare Pharmaceuticals is U24230TG2016PTC112512. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ventrocare Pharmaceuticals was incorporated on 19 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.

Rakshitha Pathuri ceased to be Director on 20 Aug 2018. Latha Kiran Chowdavaram was appointed as Director on 16 Apr 2018. Jagadeeswar Reddy Chowdavaram was appointed as Director on 19 Oct 2016. Ventrocare Pharmaceuticals has 5 board changes on record in total.

The registered office of Ventrocare Pharmaceuticals is at 3 – 3 – 811 Baghameeri Near Hanuman Temple Kukatpally, Hyderabad, Telangana, India – 500072.

Ventrocare Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

The compliance status of Ventrocare Pharmaceuticals is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.